Infosalut - Se ha identificado el síndrome de Guillain-Barré (SGB) como una posible reacción adversa muy rara asociada a la vacunación con AstraZeneca
Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology
Guillain-Barre syndrome: Johnson and Johnson vaccine fit increase risk of nerve disorder - US FDA warn - BBC News Pidgin
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1 | BMJ Case Reports
La EMA pide estar alerta a signos del Guillain-Barré con AstraZeneca
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1 | BMJ Case Reports
Unusual Variant of Guillain-Barré Syndrome Linked to COVID Vaccines | MedPage Today
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/elfinanciero/O6YEJGQB55A7HGEAIW7N2YA3Z4.jpg "Vacuna de AstraZeneca: regulador europeo pide estar alerta a signos de síndrome de Guillain-Barré – El Financiero")
Vacuna de AstraZeneca: regulador europeo pide estar alerta a signos de síndrome de Guillain-Barré – El Financiero
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination? - ScienceDirect
Guillain-Barre syndrome - Symptoms and causes - Mayo Clinic
Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y riesgo de síndrome de Guillain-Barré - Agencia Española de Medicamentos y Productos Sanitarios
Agencia Europea del Medicamento señala el síndrome Guillain-Barré como un posible efecto secundario “muy inusual” de vacuna AstraZeneca contra el Covid-19 - La Tercera
J&J Covid-19 vaccine may trigger neurological condition in rare cases
Case reports describe 'unusual' Guillain-Barre variants following COVID-19 vaccination
Cureus | Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
Could the AstraZeneca vaccine cause Guillain-Barré syndrome? We don't know yet — but there's minimal cause for concern
Frontiers | Guillain–Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases
Síndrome Guillain-Barré: qué es y cómo se relaciona con las vacunas | Ecología | La Revista | El Universo
J&J Vaccine and Guillain-Barré Syndrome: Information on the FDA Warning > News > Yale Medicine
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis | The BMJ
La EMA pide estar alerta a signos del síndrome de Guillain-Barré con AstraZeneca
FDA Warns About Post-COVID Vax Guillain-Barré Syndrome | MedPage Today
Confirman el síndrome de Guillain-Barré como un efecto secundario de la vacuna de AstraZeneca | DiarioMedico
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OX33DVRVBRPCLAXWRSXX4OPPT4.jpg "EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot | Reuters")
EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot | Reuters
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial - The Lancet Neurology
Diagnosis and management of Guillain–Barré syndrome in ten steps | Nature Reviews Neurology
Guillain-Barré: Así es el síndrome vinculado con vacunas J&J y AstraZeneca | Sociedad | W Radio Mexico
